Terms: = Leukemia AND NCKIPSD, AF3P21, 51517, ENSG00000213672, SPIN90, WASLBP, Q9NZQ3, WISH, ORF1 AND Treatment
41 results:
1. Mucosal-associated invariant T cells in hematological malignancies: Current knowledge, pending questions.
Treiner E
Front Immunol; 2023; 14():1160943. PubMed ID: 37020559
[TBL] [Abstract] [Full Text] [Related]
2. Survey of understanding and awareness of fertility preservation in pediatric patients: Is conversation about fertility preservation unpleasant for pediatric patients?
Takae S; Iwahata Y; Sugishita Y; Iwahata H; Kanamori R; Shiraishi E; Ito K; Suzuki Y; Yamaya Y; Tanaka K; Oyama K; Keino D; Nakamura K; Odawara K; Horage Y; Meng L; Igualada A; Faizal AM; Aworet LO; Furuta S; Sakamoto M; Mori T; Kitagawa H; Suzuki N
Front Endocrinol (Lausanne); 2022; 13():1074603. PubMed ID: 36686445
[TBL] [Abstract] [Full Text] [Related]
3. treatment of CML in pregnancy.
Robertson HF; Apperley JF
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):123-128. PubMed ID: 36485083
[TBL] [Abstract] [Full Text] [Related]
4. Severe pulmonary toxicity related to carfilzomib use: a rare but serious side effect.
Sridhar A; Yohannan B; Kachira JJ; Bhama S
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35787495
[TBL] [Abstract] [Full Text] [Related]
5. [Successful child delivery in treatment-free remission of chronic myeloid leukemia after discontinuation of dasatinib].
Hirose N; Fujisawa S; Sakuma T; Matsumura A; Miyashita K; Nakajima Y; Nakajima H
Rinsho Ketsueki; 2022; 63(2):114-116. PubMed ID: 35264501
[TBL] [Abstract] [Full Text] [Related]
6. treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel.
Pavlovsky C; Abello Polo V; Pagnano K; Varela AI; Agudelo C; Bianchini M; Boquimpani C; Centrone R; Conchon M; Delgado N; Funke V; Giere I; Luise I; Meillon L; Moiraghi B; Navarro JR; Pilleux L; Prado AI; Undurraga S; Cortes J
Blood Adv; 2021 Dec; 5(23):4855-4863. PubMed ID: 34438444
[TBL] [Abstract] [Full Text] [Related]
7. Parental adjustment following their child's completion of acute lymphoblastic leukemia treatment.
McCarthy MC; Marks IR; Mulraney M; Downie P; Matson A; De Luca CR
Pediatr Blood Cancer; 2021 Nov; 68(11):e29302. PubMed ID: 34411413
[TBL] [Abstract] [Full Text] [Related]
8. Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of
Huang Y; Yu SH; Zhen WX; Cheng T; Wang D; Lin JB; Wu YH; Wang YF; Chen Y; Shu LP; Wang Y; Sun XJ; Zhou Y; Yang F; Hsu CH; Xu PF
Theranostics; 2021; 11(14):6891-6904. PubMed ID: 34093860
[No Abstract] [Full Text] [Related]
9. Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience.
Assi R; Kantarjian H; Keating M; Pemmaraju N; Verstovsek S; Garcia-Manero G; Ravandi F; Borthakur G; Dahl J; Jabbour E; Cortes JE
Leuk Lymphoma; 2021 Apr; 62(4):909-917. PubMed ID: 33283580
[TBL] [Abstract] [Full Text] [Related]
10. [Delivery of a Healthy Newborn by the Partner of a Patient with CML Undergoing treatment with Nilotinib].
Aota Y; Udagawa S; Honda T; Okuda Y; Gotoh A
Gan To Kagaku Ryoho; 2020 May; 47(5):811-813. PubMed ID: 32408325
[TBL] [Abstract] [Full Text] [Related]
11. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.
Bogaert DJ; Laureys G; Naesens L; Mazure D; De Bruyne M; Hsu AP; Bordon V; Wouters E; Tavernier SJ; Lambrecht BN; De Baere E; Haerynck F; Kerre T
Br J Haematol; 2020 Mar; 188(5):768-773. PubMed ID: 31710708
[TBL] [Abstract] [Full Text] [Related]
12. An evaluation of enasidenib for the treatment of acute myeloid leukemia.
Del Principe MI; Paterno G; Palmieri R; Maurillo L; Buccisano F; Venditti A
Expert Opin Pharmacother; 2019 Nov; 20(16):1935-1942. PubMed ID: 31454277
[No Abstract] [Full Text] [Related]
13. Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid leukemia Patients in Clinical Practice.
Almeida A; Pierdomenico F; Guerrero BP; Saraiva F; Montalvão A; Coutinho J; Mariz M; Melo T; Santos MJ; Pereira A; Cerveira N
Acta Med Port; 2019 Aug; 32(7-8):550-557. PubMed ID: 31445538
[TBL] [Abstract] [Full Text] [Related]
14. Interruption or Discontinuation of Tyrosine Kinase Inhibitor treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.
Devos T; Verhoef G; Steel E; Mazure D; Lewalle P; Bron D; Berneman Z; Benghiat FS; Mineur P; Theunissen K; Zachée P; Doyen C; Put N; Lejeune M; Van Eygen K; Havelange V; Reusens M; Pluymers W; Peeters K
Acta Haematol; 2019; 142(4):197-207. PubMed ID: 31163431
[TBL] [Abstract] [Full Text] [Related]
15. NCCN Guidelines Updates: Discontinuing TKI Therapy in the treatment of Chronic Myeloid leukemia.
Shah NP
J Natl Compr Canc Netw; 2019 May; 17(5.5):611-613. PubMed ID: 31117031
[TBL] [Abstract] [Full Text] [Related]
16. Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Cappell K; Sundaram V; Park A; Shiraz P; Gupta R; Jenkins P; Periyakoil VSJ; Muffly L
Biol Blood Marrow Transplant; 2018 May; 24(5):1035-1040. PubMed ID: 29371107
[TBL] [Abstract] [Full Text] [Related]
17. Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy.
Shiseki M; Yoshida C; Takezako N; Ohwada A; Kumagai T; Nishiwaki K; Horikoshi A; Fukuda T; Takano H; Kouzai Y; Tanaka J; Morita S; Sakamoto J; Sakamaki H; Inokuchi K
Int J Clin Oncol; 2017 Oct; 22(5):972-979. PubMed ID: 28550414
[TBL] [Abstract] [Full Text] [Related]
18. Synergistic induction of apoptosis in B-cell chronic lymphocytic leukemia cells after treatment with all-trans retinoic acid in combination with interleukin-21 and rituximab.
Abbaszadeh-Goudarzi K; Shokri F; Hosseini M; Jadidi-Niaragh F; Ghalamfarsa G; Saboor-Yaraghi AA
J Cancer Res Ther; 2016; 12(4):1278-1283. PubMed ID: 28169240
[TBL] [Abstract] [Full Text] [Related]
19. Pregnancy: part of life in chronic myelogenous leukemia.
Law AD; Dong Hwan Kim D; Lipton JH
Leuk Lymphoma; 2017 Feb; 58(2):280-287. PubMed ID: 27389567
[TBL] [Abstract] [Full Text] [Related]
20. The association between glucocorticoid therapy and BMI z-score changes in children with acute lymphoblastic leukemia.
Arpe ML; Rørvig S; Kok K; Mølgaard C; Frandsen TL
Support Care Cancer; 2015 Dec; 23(12):3573-80. PubMed ID: 25894880
[TBL] [Abstract] [Full Text] [Related]
[Next]
